I think you need to do a bit more research if you think that the current BlueGen's are being sold above cost price.The only thing that will drive down the cost price (and thus the retail price) is a substantial volume order. So we wait.
MSB Mesoblast resubmits US FDA application for approval of Ryoncil in children with graft vs host disease; shares dip -4%
